Genética y Clínica de las Neoplasias Hematológicas y el Trasplante Hematopoyético

Martínez, IR; Avendaño-Solá, C; Da Ros, CV; Llobet, AB; Erce, JAG; Fraile, MIG; Domínguez, LG; Andrés, IV; Velasco, JA; Rodríguez, VPG; Contreras, E; Uranga, SU; Herraiz, ALP; Jimenez-Marco, T; Pérez, AMO; Rodríguez, JLA; Pérez-Olmeda, M; Ramos-Martínez, A; Velasco-Iglesias, A; Cabrera, JLB; Duarte, RF.

Factors related to the development of high antibody titres against SARS-CoV-2 in convalescent plasma donors from the ConPlas-19 trial

VOX SANGUINIS. 2023; 119(1): 27-33 Nº de citas: 2 [doi:10.1111/vox.13561]

García-Morin, M; Bardón-Cancho, EJ; Beléndez, C; Dulín, E; Blanco-Soto, P; Puertas-López, C; Prieto-Medina, M; Cervera-Bravo, A; Llorente-Otones, L; Pérez-Alonso, V; San-Román, S; Vecilla-Rivelles, C; López-Rubio, M; Sebastian, E; Bellón, JM; Cela, E.

Madrid Newborn Sickle Cell Disease Cohort: clinical outcomes, stroke prevention and survival

ANNALS OF HEMATOLOGY. 2023; 103(2): 373-383 Nº de citas: 1 [doi:10.1007/s00277-023-05539-1]

Rosiñol, L; Oriol, A; Rios, R; Blanchard, MJ; Jarque, I; Bargay, J; Hernández, MT; Cabañas, V; Carrillo-Cruz, E; Sureda, A; Martínez-López, J; Krsnik, I; González, ME; Casado, LF; Marti, JM; Encinas, C; de Arriba, F; Palomera, L; Sampol, A; González-Montes, Y; Cabezudo, E; Paiva, B; Puig, N; Cedena, MT; de la Cruz, J; Mateos, MV; San Miguel, J; Lahuerta, JJ; Bladé, J.

Lenalidomide and dexamethasone maintenance with or without ixazomib, tailored by residual disease status in myeloma

BLOOD. 2023; 142(18): 1518-1528 Nº de citas: 28 [doi:10.1182/blood.2022019531]

Galán, V; Beléndez, C; Echecopar, C; Estival, P; Sissini, L; Olivas, R; Bueno, D; Molina, B; Fuentes, C; Regueiro, A; Benítez, I; Plaza, M; Margarit, A; Rifón, J; Pascual, A; Palomo, P; Urtasun, A; Fuster, JL; Fuster, L; de Heredia, CD; Navarro, JMF; González-Vicent, M; Ruz, B; Pérez-Martínez, A.

Treosulfan-Based Conditioning Regimen In Pediatric Hematopoietic Stem Cell Transplantation: A Retrospective Analysis on Behalf of the Spanish Group for Hematopoietic Transplantation and Cellular Therapy (GETH-TC)

Transplantation And Cellular Therapy. 2023; 29(11): Nº de citas: 1 [doi:10.1016/j.jtct.2023.08.016]

Gaschignard, J; Koehl, B; Rees, DC; Rincón-López, E; Vanderfaeillie, A; Pascault, A; Allali, S; Cela, E; Odièvre, MH; Hau, I; Oliveira, M; Guillaumat, C; Brousse, V; de Montalembert, M; Gómez, MLN; Beldjoudi, N; Bardon-Cancho, EJ; Epalza, C.

Invasive Bacterial Infections in Children With Sickle Cell Disease: 2014-2019

PEDIATRICS. 2023; 152(4): Nº de citas: 6 [doi:10.1542/peds.2022-061061]

Ruiz-Labarta, FJ; Rodríguez, RA; Prat, AS; Burrel, LP; Moreno, JMP; Rodríguez, MS; Recarte, MPP; García-Honduvilla, N; Ortega, MA; Velasco, JA; Corral, AP; Bravo, C; De Leon-Luis, JA.

Red Blood Cell Transfusion after Postpartum Hemorrhage: Clinical Variables Associated with Lack of Postpartum Hemorrhage Etiology Identification

Journal of Clinical Medicine. 2023; 12(19): [doi:10.3390/jcm12196175]

Roy-Vallejo, E; De Córdoba-Oñate, SF; Delgado-Wicke, P; Triguero-Martínez, A; Montes, N; Carracedo-Rodríguez, R; Zurita-Cruz, N; Marcos-Jiménez, A; Lamana, A; Galván-Román, JM; García, GV; Zubiaur, P; Ciudad, M; Rabes, L; Sanz, M; Rodríguez, C; Villa, A; Rodríguez, JA; Marcos, C; Hernando, J; Diaz-Fernández, P; Abad, F; de los Santos, I; Serrano, DAR; Garcia-Vicuña, R; Fernández, CS; Gomariz, RP; Muñoz-Calleja, C; Fernández-Ruiz, E; González-Alvaro, I; Cardeñoso, L; PREDINMUN COVID Grp.

Occurrence of SARS-CoV-2 viremia is associated with genetic variants of genes related to COVID-19 pathogenesis

Frontiers In Medicine. 2023; 10: Nº de citas: 2 [doi:10.3389/fmed.2023.1215246]

Calles A; Arregui M; Suárez-González J; García-Martos M; Márquez-Rodas I; Álvarez R; Martin M.

Unleashing a Lazarus Effect With Selpercatinib in a Never-Smoker Patient With Stage IV, Chemo-Immunotherapy Refractory, RET C630Y-Mutant, Small-Cell Lung Cancer: A First Case Report.

Jco Precision Oncology. 2023; 7: Nº de citas: 2 [doi:10.1200/PO.23.00321]

Martínez-García, M; Olmos, P.

Handling Ill-Conditioned Omics Data With Deep Probabilistic Models

IEEE Journal of Biomedical and Health Informatics. 2023; 27(9): 4601-4610 Nº de citas: 1 [doi:10.1109/JBHI.2023.3279493]

Trneny, M; Avigdor, A; Mckinney, MS; Paneesha, S; Wahlin, BE; Hrom, JS; Cunningham, D; Morley, N; Canales, M; Bastos-Oreiro, M; Belada, D; Devizzi, L; Zheng, F; Demarini, DJ; Jiang, W; Jiang, P; Lynch, RC.

Parsaclisib, a PI3Kd inhibitor, in relapsed and refractory follicular lymphoma (CITADEL-203): a phase 2 study

Eclinicalmedicine. 2023; 63: Nº de citas: 4 [doi:10.1016/j.eclinm.2023.102130]

Vicente-Valor, J; Rodriguez-Gonzalez, C; Ferris-Villanueva, M; Chamorro-de-Vega, E; Romero-Jimenez, R; Gomez-Costas, D; Herrero-Bermejo, S; Tejerina-Picado, F; Osorio-Prendes, S; Oarbeascoa-Royuela, G; Herranz-Alonso, A; Sanjurjo-Saez, M.

Remdesivir and SARS-CoV-2 monoclonal antibodies to prevent COVID-19 progression in hematological patients: an observational study

PHARMACOLOGICAL REPORTS. 2023; 75(5): 1254-1264 Nº de citas: 1 [doi:10.1007/s43440-023-00519-8]

Lobato, MPT; Navarro-Marchena, L; de Noriega, I; Olive, MM; Solano-Paez, P; Perez, ER; Colino, CG; Abos, MG; Garcia, MT; Labarga, BH; Rodriguez, RP; Ibor, BL; Lassaletta, A; Isaak, AM; Martinez, OC; Arrese, LV; Sales, AL; Subias, LG; Vega, CM; Moreno, L; Quiroga-Cantero, E.

Palliative care for children with central nervous system tumors: results of a Spanish multicenter study

CLINICAL & TRANSLATIONAL ONCOLOGY. 2023; 26(3): 786-795 [doi:10.1007/s12094-023-03301-7]

Salmeron-Villalobos, J; Castrejon-de-Anta, N; Guerra-Garcia, P; Ramis-Zaldivar, JE; Lopez-Guerra, M; Mato, S; Colomer, D; Diaz-Crespo, F; Menarguez, J; Garrido-Pontnou, M; Andres, M; Garcia-Fernandez, E; Llavador, M; Frigola, G; Garcia, N; Gonzalez-Farre, B; Martin-Guerrero, I; Garrido-Colino, C; Astigarraga, I; Fernandez, A; Verdu-Amoros, J; Gonzalez-Muniz, S; Gonzaaez, B; Celis, V; Campo, E; Balague, O; Salaverria, I.

Decoding the molecular heterogeneity of pediatric monomorphic post-solid organ transplant lymphoproliferative disorders

BLOOD. 2023; 142(5): 434-445 Nº de citas: 10 [doi:10.1182/blood.2022019543]

Pereira, MDM; Colombatti, R; Alvarez, F; Bartolucci, P; Bento, C; Brunetta, AL; Cela, E; Christou, S; Collado, A; de Montalembert, M; Dedeken, L; Fenaux, P; Galacteros, F; Glenthoj, A; Valle, VG; Kattamis, A; Kunz, J; Lobitz, S; McMahon, C; Pellegrini, M; Reidel, S; Russo, G; Freire, MS; van Beers, E; Kountouris, P; Gulbis, B.

Sickle cell disease landscape and challenges in the EU the ERN-EuroBloodNet perspective

Lancet Haematology. 2023; 10(8): 687-694 Nº de citas: 6 [doi:10.1016/S2352-3026(23)00182-5]

Bermejo-Gomez, A; Aguilera-Alonso, D; Rincon-Lopez, EM; Catalan-Alonso, P; Bardon-Cancho, EJ; Garcia-Morin, M; Manrique-Rodriguez, S; Navarro-Gomez, ML.

Use of Monoclonal Antibodies in a Pediatric Patient With Severe Combined Immunodeficiency and Persistent SARS-CoV-2 Infection

PEDIATRIC INFECTIOUS DISEASE JOURNAL. 2023; 42(8): 290-292 [doi:10.1097/INF.0000000000003938]

Hamadani, M; Coleman, M; Boccia, R; Duras, J; Hutchings, M; Zinzani, PL; Cordoba, R; Oreiro, MB; Williams, V; Liu, HQ; Stouffs, M; Langmuir, P; Sancho, JM.

Safety and efficacy of parsaclisib in combination with obinutuzumab and bendamustine in patients with relapsed or refractory follicular lymphoma (CITADEL-102): A phase 1 study

HEMATOLOGICAL ONCOLOGY. 2023; 41(5): 848-857 [doi:10.1002/hon.3209]

Penas-Utrilla, D; Perez-Lago, L; Molero-Salinas, A; Estevez, A; Sanz, A; Herranz, M; Martinez-Laperche, C; Andres-Zayas, C; Veintimilla, C; Catalan, P; Alonso, R; Munoz, P; de Viedma, DG.

Systematic genomic analysis of SARS-CoV-2 co-infections throughout the pandemic and segregation of the strains involved

Genome Medicine. 2023; 15(1): Nº de citas: 4 [doi:10.1186/s13073-023-01198-z]

Gavriilaki, E; Sakellari, I; Labopin, M; Bornhauser, M; Hamladji, RM; Casper, J; Edinger, M; Zak, P; Yakoub-Agha, I; Ciceri, F; Schroeder, T; Zuckerman, T; Kobbe, G; Yeshurun, M; Narni, F; Finke, J; Diez-Martin, JL; Berceanu, A; Hilgendorf, I; Verbeek, M; Olivieri, A; Savani, B; Spyridonidis, A; Nagler, A; Mohty, M.

Survival advantage of treosulfan plus fludarabine (FT14) compared to busulfan plus fludarabine (FB4) in active acute myeloid leukemia post allogeneic transplantation: an analysis from the European Society for Blood and Marrow Transplantation (EBMT) Acute Leukemia Working Party (ALWP)

BONE MARROW TRANSPLANTATION. 2023; 58(10): 1084-1088 Nº de citas: 4 [doi:10.1038/s41409-023-02028-x]